FIELD: pharmaceutics.
SUBSTANCE: invention relates to a coating composition suitable for coating pharmaceutical or nutriceutical dosage form, comprising a core comprising one or more pharmaceutical or nutraceutical active ingredients, wherein the coating composition is comprising at least 20% by weight of an enteric core/shell polymer composition, derived from an emulsion polymerisation process, wherein the core of the core/shell polymer composition is formed by a water-insoluble, cross-linked polymer or copolymer, containing polymerised links of n-butyl acrylate, n-butyl methacrylate or methyl methacrylate and ethylene glycol dimethacrylate, and the shell of the core/shell polymer composition is formed by an anionic polymer or copolymer, containing polymerised links from 10 to 40 wt% of acrylic or methacrylic acid, from 10 to 50 wt% of ethyl acrylate and from 10 to 80 wt% C4-C18-alkyl Ester of acrylic acid or methacrylic acid.
EFFECT: coating of the dosage form.
13 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTICAL DOSAGE FORMS | 2011 |
|
RU2606588C2 |
GASTRAL-RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINABILITY TO THE ETHANOL IMPACT | 2012 |
|
RU2649806C2 |
PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION | 2010 |
|
RU2604861C2 |
FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN INTESTINE | 2016 |
|
RU2681315C2 |
DRUG FORM FOR DELIVERY OF MEDICATION INTO LARGE INTESTINE | 2007 |
|
RU2478372C2 |
PHARMACEUTICAL FORM FOR DRUG DELIVERY TO THE COLON | 2007 |
|
RU2646825C2 |
CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE COMPOSITIONS AND THEIR USE | 2018 |
|
RU2782016C2 |
PHARMACEUTICAL COMPOSITIONS | 2005 |
|
RU2447885C2 |
OMEPRAZOLE PHARMACEUTICAL PREPARATION | 1998 |
|
RU2207121C2 |
TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
Authors
Dates
2016-10-10—Published
2011-06-17—Filed